The Palmitoylation of Metastasis Suppressor KAI1/CD82 Is Important for Its Motility- and Invasiveness-Inhibitory Activity
暂无分享,去创建一个
Bin Zhou | Bin Zhou | M. Reddivari | Xin A. Zhang | Li Liu | Muralidhar Reddivari | Xin A Zhang | Li Liu
[1] W. Isaacs,et al. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. , 1996, Cancer research.
[2] H. Sadeghi,et al. Palmitoylation of the V2 vasopressin receptor. , 1997, Molecular pharmacology.
[3] M. Hemler. Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. , 2003, Annual review of cell and developmental biology.
[4] J. Kreidberg,et al. Palmitoylation of tetraspanin proteins: modulation of CD151 lateral interactions, subcellular distribution, and integrin-dependent cell morphology. , 2002, Molecular biology of the cell.
[5] P. P. Di Fiore,et al. Endocytosis and mitogenic signaling. , 1999, Current opinion in cell biology.
[6] M. Marsh,et al. The on-off story of protein palmitoylation. , 2003, Trends in cell biology.
[7] G. Freeman,et al. The 4F9 antigen is a member of the tetra spans transmembrane protein family and functions as an accessory molecule in T cell activation and adhesion. , 1993, Cellular immunology.
[8] E. Odintsova,et al. Expression of the palmitoylation-deficient CD151 weakens the association of alpha 3 beta 1 integrin with the tetraspanin-enriched microdomains and affects integrin-dependent signaling. , 2002, The Journal of biological chemistry.
[9] Eric Rubinstein,et al. Differential stability of tetraspanin/tetraspanin interactions: role of palmitoylation , 2002, FEBS letters.
[10] Y Iwamoto,et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. , 1987, Cancer research.
[11] C. Slaughter,et al. Molecular cloning and expression of palmitoyl-protein thioesterase. , 1994, The Journal of biological chemistry.
[12] K. Vuori,et al. CAS/Crk Coupling Serves as a “Molecular Switch” for Induction of Cell Migration , 1998, The Journal of cell biology.
[13] G. Borisy,et al. Cell Migration: Integrating Signals from Front to Back , 2003, Science.
[14] R. Doms,et al. Palmitoylation of CCR5 Is Critical for Receptor Trafficking and Efficient Activation of Intracellular Signaling Pathways* , 2001, The Journal of Biological Chemistry.
[15] S. Grimm,et al. The metastasis suppressor gene C33/CD82/KAI1 induces apoptosis through reactive oxygen intermediates , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[16] A. Takaoka,et al. Reduced Invasive and Metastatic Potentials of KAI1‐transfected Melanoma Cells , 1998, Japanese journal of cancer research : Gann.
[17] Lei Liu,et al. EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells. , 2003, Cancer research.
[18] M. Imamura,et al. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma , 1999, British Journal of Cancer.
[19] R. Schülein,et al. Properties of the human arginine vasopressin V2 receptor after site-directed mutagenesis of its putative palmitoylation site. , 1996, The Biochemical journal.
[20] M. Hemler,et al. Interaction of the Integrin β1 Cytoplasmic Domain with ICAP-1 Protein* , 1999, The Journal of Biological Chemistry.
[21] A. Hall,et al. Cell migration: Rho GTPases lead the way. , 2004, Developmental biology.
[22] J. Slupsky,et al. The functional glycoprotein CD9 is variably acylated: localization of the variably acylated region to a membrane-associated peptide containing the binding site for the agonistic monoclonal antibody 50H.19. , 1988, Biochimica et biophysica acta.
[23] T. Pollard,et al. Cellular Motility Driven by Assembly and Disassembly of Actin Filaments , 2003, Cell.
[24] J. Linden,et al. Palmitoylation of the recombinant human A1 adenosine receptor: enhanced proteolysis of palmitoylation-deficient mutant receptors. , 1999, The Biochemical journal.
[25] K. Handa,et al. Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation. , 1999, Cancer research.
[26] K. Akakura,et al. Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer. , 1996, The American journal of pathology.
[27] Krista L. Clark,et al. CD81 Associates with 14-3-3 in a Redox-regulated Palmitoylation-dependent Manner* , 2004, Journal of Biological Chemistry.
[28] Careen K. Tang,et al. KAI1 protein is down-regulated during the progression of human breast cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[29] D. Gerlier,et al. A physical and functional link between cholesterol and tetraspanins , 2003, European journal of immunology.
[30] Y. Percherancier,et al. Palmitoylation-dependent Control of Degradation, Life Span, and Membrane Expression of the CCR5 Receptor* , 2001, The Journal of Biological Chemistry.
[31] P. P. D. Fiore,et al. Endocytosis and mitogenic signaling. , 1999 .
[32] K. Boesze-Battaglia,et al. Association of a Photoreceptor-specific Tetraspanin Protein, ROM-1, with Triton X-100-resistant Membrane Rafts from Rod Outer Segment Disk Membranes* , 2002, The Journal of Biological Chemistry.
[33] E. Odintsova,et al. Attenuation of EGF receptor signaling by a metastasis suppressor, the tetraspanin CD82/KAI-1 , 2000, Current Biology.
[34] N. Kohno,et al. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients. , 1998, The American journal of pathology.
[35] F. Berditchevski. Complexes of tetraspanins with integrins: more than meets the eye. , 2001, Journal of cell science.
[36] P. Jackson,et al. Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[37] J. Slupsky,et al. Myristic acid is incorporated into the two acylatable domains of the functional glycoprotein CD9 in ester, but not in amide bonds. , 1990, Biochimica et biophysica acta.
[38] G. Bazzoni,et al. Phosphorylation of a conserved integrin alpha 3 QPSXXE motif regulates signaling, motility, and cytoskeletal engagement. , 2001, Molecular biology of the cell.
[39] K. Handa,et al. Tetraspanin CD9 Is a “Proteolipid,” and Its Interaction with α3 Integrin in Microdomain Is Promoted by GM3 Ganglioside, Leading to Inhibition of Laminin-5-dependent Cell Motility* , 2002, The Journal of Biological Chemistry.
[40] H. Namba,et al. Palmitoylation of human thyrotropin receptor: slower intracellular trafficking of the palmitoylation-defective mutant. , 1998, Endocrinology.
[41] Thomas D Pollard,et al. Cellular Motility Driven by Assembly and Disassembly of Actin Filaments , 2003, Cell.
[42] K. Fukudome,et al. Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive T cells , 1992, Journal of virology.
[43] M. Hemler,et al. Transmembrane-4 Superfamily Proteins Associate with Activated Protein Kinase C (PKC) and Link PKC to Specific β1 Integrins* , 2001, The Journal of Biological Chemistry.
[44] E. Odintsova,et al. Tetraspanin CD82 regulates compartmentalisation and ligand-induced dimerization of EGFR , 2003, Journal of Cell Science.
[45] S. Levy,et al. The tetraspanin superfamily: molecular facilitators , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[46] S. Takahashi,et al. Structure and membrane topology of TAPA-1. , 1991, The Journal of biological chemistry.
[47] M. Hung,et al. KAI1 metastasis suppressor gene is frequently down-regulated in cervical carcinoma. , 2001, The American journal of pathology.
[48] J. Gruenberg,et al. Endocytosis and signaling cascades: a close encounter , 2001, FEBS letters.
[49] M. Bretscher,et al. Membrane traffic during cell locomotion. , 1998, Current opinion in cell biology.
[50] M. Higashiyama,et al. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. , 1996, Cancer research.
[51] J. Barrett,et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. , 1995, Science.
[52] R. Deschenes,et al. New insights into the mechanisms of protein palmitoylation. , 2003, Biochemistry.
[53] M. Linder,et al. Signalling functions of protein palmitoylation. , 1998, Biochimica et biophysica acta.
[54] S. Levy,et al. The Tetraspanin CD81 Is Necessary for Partitioning of Coligated CD19/CD21-B Cell Antigen Receptor Complexes into Signaling-Active Lipid Rafts 1 , 2004, The Journal of Immunology.
[55] J. Barrett,et al. Loss of KAI1 expression in the progression of colorectal cancer. , 1999, Cancer research.
[56] M. Resh. Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. , 1999, Biochimica et biophysica acta.
[57] Careen K. Tang,et al. Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells. , 2001, Cancer research.
[58] Xin A. Zhang,et al. Requirement of the p130CAS-Crk Coupling for Metastasis Suppressor KAI1/CD82-mediated Inhibition of Cell Migration* , 2003, Journal of Biological Chemistry.
[59] M. Hemler,et al. Evaluation of Prototype Transmembrane 4 Superfamily Protein Complexes and Their Relation to Lipid Rafts* , 2001, The Journal of Biological Chemistry.
[60] M. Hemler,et al. Function of the tetraspanin CD151-alpha6beta1 integrin complex during cellular morphogenesis. , 2002, Molecular biology of the cell.
[61] J. Lechner,et al. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). , 1979, Investigative urology.
[62] E. Odintsova,et al. Expression of the Palmitoylation-deficient CD151 Weakens the Association of α3β1 Integrin with the Tetraspanin-enriched Microdomains and Affects Integrin-dependent Signaling* , 2002, The Journal of Biological Chemistry.